970 related articles for article (PubMed ID: 32462937)
1. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
3. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
4. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.
Vlachavas EI; Bohn J; Ückert F; Nürnberg S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802234
[TBL] [Abstract][Full Text] [Related]
5. From flesh to bones: Multi-omics approaches in forensic science.
Procopio N; Bonicelli A
Proteomics; 2024 Jun; 24(12-13):e2200335. PubMed ID: 38683823
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer.
Matsuoka T; Yashiro M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892067
[TBL] [Abstract][Full Text] [Related]
7. Preface on application of omics technologies in cancer biology and therapy.
Georgakilas AG
Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
[No Abstract] [Full Text] [Related]
8. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
[TBL] [Abstract][Full Text] [Related]
9. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective.
Hoseini SH; Enayati P; Nazari M; Babakhanzadeh E; Rastgoo M; Sohrabi NB
J Gastrointest Cancer; 2024 Jun; 55(2):497-510. PubMed ID: 38168859
[TBL] [Abstract][Full Text] [Related]
10. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
11. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
12. Omics-based biomarkers: current status and potential use in the clinic.
Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
[TBL] [Abstract][Full Text] [Related]
13. [Multi-omics technology and its applications to life sciences: a review].
Liu J; Li W; Wang L; Li J; Li E; Luo Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3581-3593. PubMed ID: 36305394
[TBL] [Abstract][Full Text] [Related]
14. Omics Profiling in Precision Oncology.
Yu KH; Snyder M
Mol Cell Proteomics; 2016 Aug; 15(8):2525-36. PubMed ID: 27099341
[TBL] [Abstract][Full Text] [Related]
15. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
16. A multi-omics perspective of CAR T cell therapy.
Yang J; Chen Y; Han L
Clin Transl Med; 2023 May; 13(5):e1274. PubMed ID: 37228183
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Omics Analyses Enabled by Microchip Technologies.
Deng Y; Finck A; Fan R
Annu Rev Biomed Eng; 2019 Jun; 21():365-393. PubMed ID: 30883211
[TBL] [Abstract][Full Text] [Related]
18. Omics sciences and precision medicine in melanoma.
Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
[TBL] [Abstract][Full Text] [Related]
19. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
[TBL] [Abstract][Full Text] [Related]
20. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]